Exabis Library
Welcome to the e-CCO Library!
P0222: Predicting corticosteroid failure in Acute Severe Ulcerative Colitis at admission using the ADMIT-ASC score.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0223: In Vitro Fertilization in Women with Inflammatory Bowel Disease – Clinical Characteristics and Outcomes
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0224: Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies – Insights from the IUS IG-IBD (Italian Group for the Study of Inflammatory Bowel Disease) Master Program
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0225: Histone Serotonylation (H3Q5ser): A Novel Epigenetic Signature in Crohn’s Disease Pathogenesis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0226: Postoperative recurrence after a definitive ostomy in Crohn's disease. A nationwide retrospective series from the Eneida registry.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0227: Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0228: Evolution of the IBD-Disability Index in a cohort of recently diagnosed CD patients: results from the prospective CROCO (Crohn´s Disease Cohort) Study
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0229: Evaluation of anorectal function and structure in patients with perianal Crohn's disease with a novel 3-D high-definition anorectal manometry technology
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P022: A correlation of serum Fibroblast Growth Factor 21 level with inflammatory markers and indicators of nutritional status in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P022: Galectin-3, galectin-9, and galectin-3 binding protein in patients with inflammatory bowel diseases
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P022: MET deletion in MRP8+ neutrophils is protective during DDS-induced colitis via Th17 pathway
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P022: Parthenolide enhances the efficacy of anti-tumour effect of balsalazide in human colon cancer cells and colitis-associated colorectal cancer by blockade of NF-kB activation
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P022: Pathologic involvement of the farnesoid X receptor/fibroblast growth factor 19 axis to the Crohn’s disease early postsurgical recurrence.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P022: Severe disease activity in UC is associated with mucosal hypoxia measured endoscopically
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P022: Transcriptional biomarkers for vedolizumab therapy response in patients with moderate to severe Ulcerative Colitis.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P023 Identification of regulated mechanistic pathways and genes to protect intestinal barrier injury by larazotide acetate in an IBD microenvironment
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0230: Prognostic factors and predictive model development for pediatric Inflammatory Bowel Disease with IL-10RA deficiency: A retrospective cohort study.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0231: Validation and Reformation of the Red Flags Index: Build a Tool of the Early Diagnosis of Crohn's Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0232: Increasing awareness of joint symptoms in Inflammatory Bowel Disease clinic using recognised clinical joint pain scoring symptoms may aid early diagnosis of spondyloarthropathy
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0233: Prevalence and characteristics of short bowel syndrome in Crohn's disease: a retrospective observational single centre study.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM